There was selling of shares by entities who were paid in shares for the assets we bought or for money we borrowed. The PPS should have never been where it was. With the selling reduced Generex may just be returning to where it should have been. No one anticipated it would take so long to get things in order and then Covid-19 hit at the worst possible time for Generex's plan to be implemented. On the flip side Covid-19 has presented an opportunity that might dwarf all others in the near future.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links